Skip to main content

and
Your search also matched 7 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients

Include preview-only content
  1. Article

    Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

    Raffaella Greco, Jorinde D. Hoogenboom in Bone Marrow Transplantation (2023)

  2. Article

    Open Access

    A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease

    X-linked chronic granulomatous disease is a rare disease caused by mutations in the CYBB gene. While more extensive knowledge is available on genetics, pathogenesis, and possible therapeutic options, mitochond...

    Maddalena Migliavacca, Luca Basso Ricci, Giada Farinelli in Journal of Clinical Immunology (2022)

  3. Article

    Open Access

    Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

    Post-transplant cyclophosphamide (PTCy) has emerged as a promising graft-versus-host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, no studies have repor...

    Lorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro in Bone Marrow Transplantation (2022)

  4. Article

    Open Access

    Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

    The outcome of refractory/relapsed (R/R) acute leukemias is still dismal and their treatment represents an unmet clinical need. However, allogeneic transplantation (allo-HSCT) remains the only potentially cura...

    Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori in Bone Marrow Transplantation (2022)

  5. Article

    COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome

    Maria Teresa Lupo-Stanghellini, Elisabetta Xue in Bone Marrow Transplantation (2021)

  6. Article

    Open Access

    Ultrasound elastography techniques for diagnosis and follow-up of hepatic veno-occlusive disease

    Lorenzo Lazzari, Paolo Marra, Raffaella Greco, Fabio Giglio in Bone Marrow Transplantation (2019)